[A case of expanding pulmonary aspergilloma]

Y Nakagawa1, K Shimazu, M Ebihara

  • 1Department of Internal Medicine, National Kumamoto South Hospital, Japan.

Nihon Kyobu Shikkan Gakkai Zasshi
|May 6, 1998
PubMed

Insights

A 60-year-old woman developed semi-invasive pulmonary aspergillosis. This condition progressed from an aspergilloma in a pre-existing tuberculosis cavity, invading the surrounding lung tissue.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Radiology

Background:

  • A 60-year-old female with a history of pulmonary tuberculosis presented with a cavitary lesion in the right upper lung.
  • Radiographic findings over 16 years showed the development and progression of a fungus ball within the cavity.

Observation:

  • Initial chest radiographs in 1980 revealed a small cavitary lesion. By 1984, a fungus ball was noted with pleural thickening.
  • By 1994, the fungus ball's margins became ill-defined with surrounding infiltrative shadows, and Aspergillus antigen tests were positive with elevated serum toxins.
  • Radiographs in 1996 demonstrated substantial enlargement of the fungus ball.

Findings:

  • The case is diagnosed as semi-invasive pulmonary aspergillosis.
  • Progression occurred via direct invasion from an aspergilloma into the adjacent cavitary wall.

Implications:

  • This case highlights the potential for aspergilloma to evolve into semi-invasive pulmonary aspergillosis in patients with prior lung cavities.
  • Early recognition and monitoring of changes in aspergilloma are crucial for timely diagnosis and management of invasive fungal infections.

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...